Concerned about US vaccine misinformation and access, public health experts start Vaccine Integrity Project
Concerned that the nation's health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take action to curb their use, a group of public health experts is working to put pieces in place to respond.
The initiative, the Vaccine Integrity Project, will be funded by a foundation backed by Walmart heiress Christy Walton and has a steering committee helmed by former US Food and Drug Administration Commissioner Dr. Margaret Hamburg and former National Academy of Medicine President Dr. Harvey Fineberg, said Dr. Michael Osterholm, who is leading the initiative and who serves as director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
The effort will consider what's needed to safeguard vaccine policy and use in the US, including whether there's a need for a new independent body to evaluate vaccine safety and effectiveness, Osterholm said ahead of Thursday's announcement.
'There have been conversations happening for months now across the public health community about, 'what will we do if US government vaccine information becomes corrupted or the system that helps to ensure their safety and efficacy are compromised?' ' he said.
The initiative is being formed in response to actions by US Health and Human Services Secretary Robert F. Kennedy Jr., who has spread mixed messages about the measles vaccine amid a deadly outbreak, accused advisers to federal health agencies of conflicts of interest and pledged to start a major autism study that experts fear will falsely tie the condition to vaccines.
The Vaccine Integrity Project's first move will be to hold a series of information-gathering sessions, pulling together experts from local public health departments, medical associations, academia, public policy, industry and others.
The initial goal is to determine 'what is important to have going forward if, in fact, there should be compromise by the federal government in terms of our vaccine enterprise,' Osterholm said. 'We can't say at this point that that's happened, but we don't want to wait until the moment it might happen, and we have enough signals that that is.'
He pointed to Kennedy's vaccine comments, as well as moves like some Minnesota state legislators' introduction of a bill this week 'to declare that mRNA vaccine technology is a weapon of mass destruction and that it should be immediately taken off the market and anyone using it would be liable for criminal activity.'
'Who's going to respond to that?' Osterholm asked. 'Is anybody at the federal government level going to respond to activities like that? That's a question I think we are left, at this point, unanswered.'
The 'initial feedback phase,' as he called it, will start this month and last until early August.
'We don't know what's this is going to look like at the end, but we'll only find out by listening to all of these groups,' Osterholm said. 'At the end of that process, hopefully we can all look at it and come to a similar conclusion, that this is what's necessary or not necessary to protect the vaccine enterprise.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Newly approved therapy could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that's the No. 1 cause of hospitalization in infants. The US Food and Drug Administration has approved a new monoclonal antibody to help prevent infection, according to an announcement late Monday from drugmaker Merck. The therapy, Enflonsia, is designed to be given in a single 105-milligram shot to protect newborns and infants from mild, moderate or severe RSV through all five months of their first virus season, which typically starts in the fall and goes through the next spring. Study materials that Merck submitted to the FDA for its approval showed that the antibody had a similar safety profile as a placebo. The most common adverse reactions from Enflonsia were mild and included injection-site swelling and a rash in a small number of infants. In a mid- to late-stage trial, Enflonsia reduced RSV-associated hospitalizations in infants more than 84% compared with a placebo. RSV can sometimes turn into serious lower respiratory infections like pneumonia, but the shot also reduced lower respiratory infections that needed medical attention by more than 60% compared with a placebo. 'Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season,' Dr. Dean Y. Li, president of Merck Research Laboratories, said in a news release. 'We are committed to ensuring availability of Enflonsia in the US before the start of the upcoming RSV season to help reduce the significant burden of this widespread seasonal infection on families and health care systems.' Merck says it hopes Enflonsia will be available before the start of the 2025-26 respiratory virus season. First, it needs to be recommended by the US Centers for Disease Control and Prevention, and that means going in front of the agency's Advisory Committee on Immunization Practices. It's on the agenda for the panel's meeting this month, but US Health and Human Services Secretary Robert F. Kennedy removed all the members of that committee Monday. He says he will appoint new ones, but it's unclear how long that process will take. Doctors say another tool to prevent RSV cannot come soon enough. RSV is ubiquitous, one of the most common causes of childhood illness. Most kids will catch this highly contagious respiratory virus at some point before they turn 2, according to the CDC. For many healthy adults and older kids, RSV causes a mild illness like a cold. Typically, symptoms can be managed at home, and they often go away on their own. But for infants and the elderly, it can be a different story. Very young children's immune systems are just starting to learn how to fight infections, and infants have tiny airways. RSV inflames those airways, making it difficult to breathe, and can turn into a serious lower respiratory illness like bronchiolitis or pneumonia. Some of these RSV infections can be deadly. Two to three percent of infants under 6 months are hospitalized with RSV in the US every year, according to the CDC. Among children younger than 5, about 58,000 to 80,000 are hospitalized due to RSV. There's no specific medicine to treat RSV. Doctors can give an infant supportive care and oxygen, and then they essentially wait until their oxygen levels get back to normal, said Dr. Amy Edwards, director of pediatric infection control at UH Rainbow Babies and Children's Hospital in Cleveland. 'I hate RSV,' said Edwards, who was not connected with the Merck trial. 'Just to watch them struggle to breathe, and then they get scared, and then they cry, which of course makes the breathing worse, and their little lips turn blue. It's just so hard to watch.' Enflonsia joins a handful of other tools recently made available to protect babies from, although the FDA put RSV vaccine trials involving infants and young children ages 2 to 5 on hold last year after some developed severe illness. To prevent RSV in infants, the CDC currently recommends an RSV antibody made by Sanofi and AstraZeneca, called Beyfortus, which was approved in 2023. It was in short supply during that year's RSV season, although Edwards said supply started to catch up with demand in her health care system last season, and the company pledged to produce more. The other option to protect an infant is a vaccine that a person can get during pregnancy. Together, Beyfortus and the vaccine have made a difference. A CDC study published in March found that RSV-associated hospitalization rates among infants up to 7 months during 2024-25 season were lower than in seasons when those therapies weren't available. Edwards just hopes people will get protection for their infants. 'Every RSV season fills us to the gills,' she said. 'This should theoretically empty us out, if we have good uptake.'
Yahoo
a day ago
- Yahoo
1.7 Million Cartons of Eggs Recalled for Salmonella Contamination
On June 6, the United States Food & Drug Administration (FDA) announced that August Egg Company of Hilmar, CA, is recalling 1.7 million dozen cage-free and certified organic eggs. The brown eggs, which were distributed in at least nine states, have been linked to a salmonella outbreak. According to the Centers for Disease Control & Prevention (CDC), there have been 79 reported salmonella infections so far, with 21 of those people being Name: Various brands of cage-free and organic eggs Date of Recall: June 6, 2025 Plant Code Number: P-6562 or CA5330 Distribution: Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington, WyomingSalmonella can cause severe gastrointestinal symptoms, such as stomach cramps, diarrhea, and fever. The symptoms of salmonella can start anywhere from six hours after eating contaminated food to six days after exposure. The recalled eggs were distributed in California and Nevada from February 3, 2025 to May 15, 2025 with sell by dates of March 4, 2025 to June 4, 2025, The eggs were sold at grocers including Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, and Ralphs. The eggs were also distributed in Walmart stores from February 3, 2025 to May 6, 2025 with sell-by dates from March 4, 2025 to June 19, 2025. Walmarts in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois sold the recalled eggs. This recall affects numerous brands of eggs, including Simply Truth Organic, which is sold at Kroger stores, and Marketside, which is sold at Walmart. Check for a full list of brands affected by the recall. If you have one of the affected cartons of eggs in your fridge, do not eat them. Instead, the FDA recommends returning the eggs to your place of purchase for a refund. If you have questions about this recall, contact August Egg Company at 1-800-710-2554, between 9 a.m. and 5 p.m. PT. Read the original article on SIMPLYRECIPES
Yahoo
a day ago
- Yahoo
Here's what to know about the salmonella egg recall in Washington
A salmonella outbreak has sickened at least four people in Washington and has been connected to eggs distributed by a California company and sold at stores including Walmart in nine states. August Egg Company is recalling 1,700,000 dozen brown cage-free and brown certified organic eggs for potential salmonella risk. The eggs were distributed over the last four months, some with sell-by dates as late as June 19, according to the June 6 recall notice from the U.S. Food and Drug Administration. The eggs are linked to an ongoing Salmonella Enteritidis outbreak in seven states, in which 79 people have been sickened and at least 21 hospitalized, but no deaths have been reported, according to the Centers for Disease Control and Prevention. Here's more on the outbreak and a list of products recalled by August Egg Co. Most of the people sickened (63) live in California, according to the CDC. Nevada and Washington reported four illnesses each, with additional cases in Arizona (3), New Jersey (2), Nebraska (2), Kentucky (1). Ill people in Kentucky, New Jersey, and Washington reported traveling to California and Nevada before they got sick. Most of those sickened (90%) reported eating eggs, the CDC said. Some samples taken by the FDA during an inspection at August Egg Company's processing facility tested positive for the strain of salmonella similar to those related to the persons sickened in the outbreak, the CDC said. August Egg Co. said its internal food safety team is conducting its own investigation to "identify what measures can be established to prevent this situation from recurring," the company said in a statement accompanying the recall. 'It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens." USA TODAY Recall Database: Search vehicle, product and food recalls The recalled eggs were distributed beginning Feb. 3 across multiple retailers in nine states: Eggs with sell-by dates to June 4: Through May 15, eggs with those sell-by dates were distributed to Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less and Ralphs stores in California and Nevada. Eggs with sell-by dates to June 19: Through May 6, eggs with those sell-by dates were distributed to Walmart locations in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana and Illinois. August Egg Co. said consumers can identify the recalled eggs by the plant code on one side of the egg carton. They can return the eggs to the place of purchase for a refund. Consumers with questions can call the company at 1-800-710-2554, between 9 a.m. and 5 p.m. PT. Here's the products recalled with plant code and UPC. Salmonella causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms of salmonella infection — including diarrhea, fever and stomach cramps — typically arise six hours to six days after exposure and may last 4 to 7 days. Severe infections can also include aches, headaches, elevated fever, lethargy, rashes and blood in the urine or stool. Salmonella poisoning, also known as salmonellosis, is a common bacterial infection in Washington, with about 600-800 cases reported annually, according to the Washington State Department of Health. The CDC estimates that around 3,000 people die from a foodborne illness, and of those about 420 people die from Salmonella infections. Salmonella infections typically go away on their own without the need for medication, according to the state Department of Health website. "Antibiotics and antidiarrheal drugs are generally not recommended," the website states. "Some people require intravenous fluids to prevent dehydration." This article originally appeared on Kitsap Sun: Here's what to know about the salmonella egg recall in Washington
